Figure 5
From: Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen
Reduced PTEN expression is associated with shorter relapse-free survival (P=0.0030) (a) and (b) and statistical trend for shorter disease-specific survival (c) and (d) particularly in patients with tumors weakly positive for ER-α.
